Last reviewed · How we verify
NCT04360512: ANKLE_ROM
Dose-response of Talus Mobilizations
NA trial testing Posteriorization of the talus in Aging Problems in 42 participants. Terminated before completion.
29 May 2020
Quick facts
| Lead sponsor | University of Valencia |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 42 |
| Start date | 15 May 2020 |
| Primary completion | 29 May 2020 |
| Estimated completion | 14 September 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Posteriorization of the talus
Conditions studied
- Aging Problems — all drugs for Aging Problems →
Sponsor
University of Valencia
Who can join
60 and older, any sex, with Aging Problems. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ankle mobility limitations are common in older adults. A possible treatment to restore joint mobility is manual therapy based on mobilization techniques, in this case, applied on the ankle joint. Previous research had proposed different treatment volumes (one to twelve sessions), but shown a different and non-consistent degree of effectiveness according to such factor. Therefore, this work aims to determine the dose-response relationship of manual therapy (talus mobilizations) on ankle range of motion in the older adult. Secondarily, this research will appraise whether a likely improvement in ankle mobility may have an impact on the overall mobility (i.e. gait, get up from a chair).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04360512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging Problems
Currently open trials in the same condition.
- NCT07144293 — Improving Physical Ability and Cellular Senescence Elimination in HIV · Phase 2 · active not recruiting
- NCT06511297 — Metabolic Control of Aging and Disease - the MetAGE Deep Phenotyping Cohort · recruiting
- NCT06175871 — New Clinical Rehabilitation Approach for the Management of Falls Risks · NA · recruiting
- NCT06448052 — Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation · Phase 1, PHASE2 · active not recruiting
- NCT06124339 — Brain Health Virtual Reality Study · NA · recruiting
Other University of Valencia trials
Trials by the same sponsor.
- NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
- NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
- NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
- NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
- NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04360512 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Valencia
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04360512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing